NNOX Shareholder Alert: August 11, 2026 Lead Plaintiff Deadline in Nano-X Imaging Ltd. Securities Class Action - Contact Levi & KorsinskyWall Street Reassessment: Ladenburg Thalmann Slashed Its NNOX Price Target After Nano-X's $17.5 Million Impairment and Manufacturing Restructuring Revealed the Gap Between Company Promises and Operational RealityGlobeNewswireAugust 03, 2026NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nano-X Imaging Ltd. (NASDAQ: NNOX) that a securities class action has been commenced on behalf of shareholders who purchased securities between March 31, 2025 and April 17, 2026. Find out if you qualify to recover your NNOX losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. The day after Nano-X Imaging Ltd. (NASDAQ: NNOX) disclosed a $17.5 million impairment charge and a forced pivot to outsourced manufacturing, Ladenburg Thalmann cut its price target on NNOX shares from $10.60 to $9.60. That downgrade followed a 24.39% single-day stock collapse that marked the worst intraday decline for NNOX in over two years.
NNOX shares fell $0.695 per share to close at $2.155 on April 20, 2026, after the company reported a Q4 2025 net loss of $33.4 million and announced it would abandon chip manufacturing at its South Korean facility.
How Analyst Expectations Were Built on Allegedly Misleading Disclosures
Throughout the Class Period, management repeatedly assured investors and analysts that Nano-X's manufacturing operations were achieving efficiency gains. On earnings calls, executives described a "robust" pipeline, "disciplined execution," and operating expenses that were "in line" with expectations. Analysts incorporated these representations into their models and coverage.
The complaint contends that these assurances concealed a fundamental misalignment between production capacity and actual demand, as well as escalating cash burn that made the Korean facility unsustainable.
The Downgrades Begin
On April 21, 2026, one day after the corrective disclosure, Ladenburg Thalmann lowered its NNOX price target to $9.60 from $10.60, citing the approximately $17.5 million impairment of long-lived assets at the Korean manufacturing facility and the resignation of CFO Ran Daniel effective July 31, 2026.
As Seeking Alpha reported, NNOX lost approximately 17% in early trading on April 20, on track for its worst intraday decline in over two years. The outlet highlighted the net loss that "surged approximately 137% year-over-year to $33.4 million."
Analyst Coverage Timeline
March 31, 2025: Management told analysts the ARC pipeline was targeting "a few hundreds of clients" and that operating expenses were "in line," with no material changes to manufacturing channelsMay 22, 2025: CEO stated the company was "delivering what we promised" and "making progress all the time," setting a target of over 100 ARC systems in deployment by year-end 2025August 12, 2025: CFO assured analysts that operating expenses were being maintained through "efficiencies and more measurements" and that revenue would soon alleviate cash burnNovember 20, 2025: Management described "rising demand" and a "highly efficient manufacturing operation" while failing to disclose any production-demand disconnectApril 20, 2026: Corrective disclosure revealed the $17.5 million impairment, $18.0 million in total expected restructuring charges, and the need to abandon company-owned chip manufacturing entirelyApril 21, 2026: Ladenburg Thalmann cut its price target by $1.00, from $10.60 to $9.60Why Analyst Shifts Matter for NNOX Investors
"When analyst expectations are built on incomplete or misleading company disclosures, the resulting corrections can cause significant investor harm. The timeline of representations made to analysts in this case raises important questions about the accuracy of information provided to the market." -- Joseph E. Levi, Esq.
Analyst models depend on truthful company guidance. The lawsuit asserts that management's repeated assurances about efficiency, demand growth, and stable operating expenses gave analysts no basis to anticipate a $17.5 million impairment or a complete restructuring of the manufacturing model. When the truth surfaced, the repricing was swift and severe.
Speak with an attorney about recovering your NNOX investment losses or call (212) 363-7500.
LEAD PLAINTIFF DEADLINE: August 11, 2026
ABOUT LEVI & KORSINSKY, LLP
Levi & Korsinsky, LLP, Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered for investors.
Frequently Asked Questions About the NNOX Lawsuit
Q: How much did NNOX stock drop? A: Shares fell approximately 24.39%, a decline of $0.695 per share, after the company disclosed a $17.5 million impairment charge, a manufacturing restructuring plan, and the resignation of its CFO. Investors who purchased shares during the class period at artificially inflated prices may be entitled to compensation.
Q: When did Nano-X Imaging allegedly mislead investors? A: The class period runs from March 31, 2025 to April 17, 2026. During this time, the lawsuit alleges management made false or misleading statements about manufacturing efficiency and demand alignment. The alleged fraud was revealed through corrective disclosures on April 20, 2026, causing a significant stock decline.
Q: What do NNOX investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible as a class member.
Q: What if I already sold my NNOX shares? Can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: Can I join a different law firm's lawsuit instead? A: Multiple firms often file competing complaints. The court consolidates and appoints a single lead counsel. Contacting Levi & Korsinsky before August 11, 2026 ensures your losses are considered.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
COMTEX_490002877/2010/2026-08-03T10:07:00
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nano-X Imaging Ltd. (NASDAQ: NNOX) that a securities class action has been commenced on behalf of shareholders who purchased securities between March 31, 2025 and April 17, 2026. Find out if you qualify to recover your NNOX losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. The day after Nano-X Imaging Ltd. (NASDAQ: NNOX) disclosed a $17.5 million impairment charge and a forced pivot to outsourced manufacturing, Ladenburg Thalmann cut its price target on NNOX shares from $10.60 to $9.60. That downgrade followed a 24.39% single-day stock collapse that marked the worst intraday decline for NNOX in over two years.
NNOX shares fell $0.695 per share to close at $2.155 on April 20, 2026, after the company reported a Q4 2025 net loss of $33.4 million and announced it would abandon chip manufacturing at its South Korean facility.
How Analyst Expectations Were Built on Allegedly Misleading Disclosures
Throughout the Class Period, management repeatedly assured investors and analysts that Nano-X's manufacturing operations were achieving efficiency gains. On earnings calls, executives described a "robust" pipeline, "disciplined execution," and operating expenses that were "in line" with expectations. Analysts incorporated these representations into their models and coverage.
The complaint contends that these assurances concealed a fundamental misalignment between production capacity and actual demand, as well as escalating cash burn that made the Korean facility unsustainable.
The Downgrades Begin
On April 21, 2026, one day after the corrective disclosure, Ladenburg Thalmann lowered its NNOX price target to $9.60 from $10.60, citing the approximately $17.5 million impairment of long-lived assets at the Korean manufacturing facility and the resignation of CFO Ran Daniel effective July 31, 2026.
As Seeking Alpha reported, NNOX lost approximately 17% in early trading on April 20, on track for its worst intraday decline in over two years. The outlet highlighted the net loss that "surged approximately 137% year-over-year to $33.4 million."
Analyst Coverage Timeline
March 31, 2025: Management told analysts the ARC pipeline was targeting "a few hundreds of clients" and that operating expenses were "in line," with no material changes to manufacturing channelsMay 22, 2025: CEO stated the company was "delivering what we promised" and "making progress all the time," setting a target of over 100 ARC systems in deployment by year-end 2025August 12, 2025: CFO assured analysts that operating expenses were being maintained through "efficiencies and more measurements" and that revenue would soon alleviate cash burnNovember 20, 2025: Management described "rising demand" and a "highly efficient manufacturing operation" while failing to disclose any production-demand disconnectApril 20, 2026: Corrective disclosure revealed the $17.5 million impairment, $18.0 million in total expected restructuring charges, and the need to abandon company-owned chip manufacturing entirelyApril 21, 2026: Ladenburg Thalmann cut its price target by $1.00, from $10.60 to $9.60Why Analyst Shifts Matter for NNOX Investors
"When analyst expectations are built on incomplete or misleading company disclosures, the resulting corrections can cause significant investor harm. The timeline of representations made to analysts in this case raises important questions about the accuracy of information provided to the market." -- Joseph E. Levi, Esq.
Analyst models depend on truthful company guidance. The lawsuit asserts that management's repeated assurances about efficiency, demand growth, and stable operating expenses gave analysts no basis to anticipate a $17.5 million impairment or a complete restructuring of the manufacturing model. When the truth surfaced, the repricing was swift and severe.
Speak with an attorney about recovering your NNOX investment losses or call (212) 363-7500.
LEAD PLAINTIFF DEADLINE: August 11, 2026
ABOUT LEVI & KORSINSKY, LLP
Levi & Korsinsky, LLP, Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered for investors.
Frequently Asked Questions About the NNOX Lawsuit
Q: How much did NNOX stock drop? A: Shares fell approximately 24.39%, a decline of $0.695 per share, after the company disclosed a $17.5 million impairment charge, a manufacturing restructuring plan, and the resignation of its CFO. Investors who purchased shares during the class period at artificially inflated prices may be entitled to compensation.
Q: When did Nano-X Imaging allegedly mislead investors? A: The class period runs from March 31, 2025 to April 17, 2026. During this time, the lawsuit alleges management made false or misleading statements about manufacturing efficiency and demand alignment. The alleged fraud was revealed through corrective disclosures on April 20, 2026, causing a significant stock decline.
Q: What do NNOX investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible as a class member.
Q: What if I already sold my NNOX shares? Can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: Can I join a different law firm's lawsuit instead? A: Multiple firms often file competing complaints. The court consolidates and appoints a single lead counsel. Contacting Levi & Korsinsky before August 11, 2026 ensures your losses are considered.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
COMTEX_490002877/2010/2026-08-03T10:07:00
2.65% $0.02
